What payment methods are accepted?

We accept LC, T/T, D/P, PayPal, and small-amount payments.

What is the warranty or after-sales support?

We provide online support and free spare parts for all units.

Portable 1000rpm 5lpm@20psi Speed Control BLDC Small Swinging Air Compressor

Name: Portable 1000rpm 5lpm@20psi Speed Control BLDC Small Swinging Air Compressor
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 2076116755

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$100.00-120.00

50 Pieces

Sample price:US$150.00/piece.Request sample

Product profile

Customization

Available

After-sales Service

on Line Support and Free Spare Parts

Voltage

DC 12V

Model NO.

SMK60D

Weight

0.39 Kg

Air Flow Rate

14.5L/Min@2 Bar@3000 Rpm

Hall Sensor

Yes

Speed

1000,2000,3000rpm

Temperature

32° to 104°f(0° to 60°c)

Power

60W@3000 Rpm

Noise

≤52dB(a)

Work Pressure

1.4bar, 2bar

Certificate

ETL

Packaging

Honeycomb Packaging + Wooden Pallet

Dimension

90.6X47X75mm

Origin

China

HS Code

8414804990

Production Capacity

200000pieces/Year

Key features

Variable Speed Control: Adjustable speed from 1000 to 3000 RPM for precise airflow control.

Compact Portable Design: Lightweight 0.39kg unit with dimensions 90.6x47x75mm for easy transport.

ETL Safety Certified: Meets rigorous safety standards with ETL certification for reliable operation.

Integrated Hall Sensor: Built-in Hall sensor ensures accurate speed monitoring and system stability.

Flexible Voltage Options: Available in DC 12V configuration for portable and battery-powered use.

Comprehensive After-Sales: Includes online support and free spare parts for long-term maintenance.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤8.73hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.